Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser

The drugs industry closed the day down 2%. Tibet Pharmaceuticals Inc ( TBET), Momenta Pharmaceuticals Inc ( MNTA), Cardium Therapeutics Inc ( CXM), and Pacific Biosciences of California Inc ( PACB) were all decliners today within the drugs industry with Teva Pharmaceutical Industries ( TEVA) being today's featured drugs loser. Teva Pharmaceutical Industries fell 42 cents (-1.1%) to $39.11 on light volume. Throughout the day, four million shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 6.6 million shares.

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs; and proprietary branded pharmaceuticals in various therapeutic categories and active pharmaceutical ingredients worldwide. Teva Pharmaceutical Industries has a market cap of $34.9 billion and is part of the health care sector. The company has a P/E ratio of 8.3, below the average drugs industry P/E ratio of 11.3 and below the S&P 500 P/E ratio of 17.7. Shares are down 24.9% year to date as of the close of trading on Monday.

TheStreet Ratings rates Teva as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and a generally disappointing performance in the stock itself.

On the positive front, CEL-SCI Corporation ( CVM), China Biologic Products Inc ( CBPO), Idera Pharmaceuticals Inc ( IDRA), and Cyclacel Pharmaceuticals Inc ( CYCC) were all gainers within the drugs industry with Illumina Inc ( ILMN) being today's featured drugs industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF ( XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech ( BIS).

null

More from Markets

Airlines Rebuke Trump Policy of Separating Children

Airlines Rebuke Trump Policy of Separating Children

Dow Fluctuates, Nasdaq Strikes Record High

Dow Fluctuates, Nasdaq Strikes Record High

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Deutsche Bank Fined $205 Million Over Currency-Trading Violations

Deutsche Bank Fined $205 Million Over Currency-Trading Violations

Instagram Launches New Longform Video Platform

Instagram Launches New Longform Video Platform